Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$963,142
+$350,576 QoQ
Shares Held
803
+20.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
5.27%
of 13F equity value
Holder Rank
#3,177
of 4,605 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Randall & Associates Wealth Management holds $1,687,972 across 2 Drug Manufacturers - General names. LLY ranks #1 (57.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
803 | $963,142 | |
| 2 | JNJ |
Johnson & Johnson
|
2,854 | $724,830 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963,142 | 803 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $612,566 | 666 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $475,008 | 442 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $235,767 | 309 | Shares | Sole | 2025-10-16 | |
| No filing history on record for this holder in this stock. | ||||||